Genetics Generation Advancement Corp. (TPEX:4160)
Taiwan · Delayed Price · Currency is TWD 39.50
-0.55 (-1.37%)
Jun 25, 2026, 1:19 PM CST
TPEX:4160 Market Cap
TPEX:4160 has a market cap or net worth of 1.05 billion as of June 25, 2026. Its market cap has decreased by -26.85% in one year.
Market Cap
1.05B
Enterprise Value
799.61M
Revenue
609.13M
Ranking
n/a
PE Ratio
75.98
Stock Price
39.50
Market Cap Chart
Since July 15, 2011, TPEX:4160's market cap has increased from 957.80M to 1.05B, an increase of 10.07%. That is a compound annual growth rate of 0.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 1.05B | -20.68% |
| Dec 31, 2025 | 1.33B | -27.41% |
| Dec 31, 2024 | 1.83B | 85.27% |
| Dec 29, 2023 | 988.25M | 48.75% |
| Dec 30, 2022 | 664.37M | 10.48% |
| Dec 30, 2021 | 601.33M | 0.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIONET | 3.36B |
| DIVA Laboratories | 1.75B |
| Puriblood Medical | 1.07B |
| Kim Forest Enterprise | 975.20M |
| Sofiva Genomics | 814.07M |
| TFBS Bioscience | 697.04M |
| Pharmigene | 388.58M |
| Welgene Biotech | 372.87M |